FDA.reportPublic FDA data

Replenix Acne Gly-Sal 2-2 Foaming Cleanser

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
Replenix Acne Gly-Sal 2-2 Foaming Cleanser
Generic name
SALICYLIC ACID
Manufacturer
Topiderm, Inc.
Product type
HUMAN OTC DRUG
SPL set ID
811dbf95-2b39-45c5-99a2-33c3c9d19570
SPL ID
ef33baaf-fbab-483d-9c2a-fbce487ce9be
Version
4
Effective date
2019-12-19
Source export date
2026-08-01
Source partition
5
Source file
https://download.open.fda.gov/drug/label/drug-label-0005-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-08-01/5a565ce64c898c83223b815b9579cd46fb0c6d54977c3cace2133e40124f7fbb/drug-label-0005-of-0014.json.zip
Source manifest SHA-256
bdd1454d0606b622b70458a306b8a10d8a8787db06fd9f46e69c7f7a4524b630
Import run
20260801T225920Z
Imported at
2026-08-01 23:09:50
Harmonized routes table
Harmonized routes
TOPICAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only Keep away from eyes, lips, and mouth. Using other topical medications, while using this product or immediately thereafter, may increase dryness or irritation. If this occurs discontinue use and see your doctor. Keep out of the reach of children. If swallowed, get medical help or contact a Poison Control Center. Sunscreen use is recommended with any glycolic acid product and for an additional week thereafter because some individuals may be more sensitive to sunlight.